Social-Sexual Education for Individuals with Neurodevelopmental Disabilities
People with neurodevelopmental disabilities are often not given the tools to create romantic relationships in a meaningful, safe way. This puts them at risk for sexual abuse. A new educational program, tested in partnership with the UC Davis MIND...
18-Jul-2022 9:05 PM EDT
Add to Favorites
Summer Institute focused on life after high school for kids with autism, ADHD, more
The UC Davis MIND Institute’s annual Summer Institute on Neurodevelopmental Disabilities is focused on strategies to support individuals with ADHD, Down syndrome, autism and more as they prepare for life after high school. The free, virtual event...
18-Jul-2022 8:05 PM EDT
Add to Favorites
New Gene Profiling Technology Reveals Melanoma Biomarkers
New technology used by UC Davis researchers has uncovered melanoma biomarkers expressed by specific tumor cells as well as neighboring cells in the so-called tumor microenvironment. The study results may help diagnose melanoma earlier when it is...
8-Jul-2022 2:45 PM EDT
Add to Favorites
New Technique for Detecting Typhoid Infections Faster, More Accurate Than Conventional Testing, According to Study
A new technique for detecting typhoid infections is faster and more accurate than conventional testing, according to a new study. The new approach can significantly help disease monitoring and vaccination planning. An estimated 11 to 20 million...
29-Jun-2022 3:15 PM EDT
Add to Favorites
A Mother’s Blood May Carry the Secret to One Type of Autism
The reactivity of a mother’s autoantibodies to specific fetal brain protein patterns may predict the child’s diagnosis with a type of autism known as MAR ASD. MAR ASD was present in around 20% of kids with autism in Arkansas and Philadelphia...
23-Jun-2022 4:30 PM EDT
Add to Favorites
Increased Overdose and Mental Health Risks Persist Two Years After Opioid Dose Reduction
A new UC Davis Health study suggests that the increased rates of overdose and mental health crisis observed during the first year after opioid dose tapering persist through the second year. The study was published in JAMA Network Open.
13-Jun-2022 12:40 PM EDT
Add to Favorites
Dogs Inhale Immunotherapy to Test Lung Cancer Treatment
An inhaled immunotherapy successfully treated cancer in some companion dogs as part of a clinical trial conducted by UC Davis oncology and veterinary researchers. Recently published study results show potential for fighting cancer in humans as well.
9-Jun-2022 1:30 PM EDT
Add to Favorites
Internationally Renowned Cancer Researcher Joins Cancer Center’s Leadership Team
UC Davis Comprehensive Cancer Center has a new chief science officer and associate director for basic science. Xiao-Jing Wang comes from the University of Colorado Anshutz Medical Campus where she focused on skin as well as head and neck cancers
26-May-2022 11:05 AM EDT
Add to Favorites
See All News
Extreme Risk Protection Orders to Prevent Mass Shootings: What Does the Research Show?
Mass shooters frequently share their plans, creating opportunities to intervene. Experts from the UC Davis Violence Prevention Research Program provide an overview of the research on mass shootings and the “red flag” laws or extreme risk...
24-Jun-2022 9:20 AM EDT
UC Davis Health experts available for interviews in English and Spanish on contact tracing
2-Oct-2020 2:55 PM EDT
UC Davis Infectious Disease Expert Available to Comment on COVID-19 following President’s Diagnosis
2-Oct-2020 12:35 PM EDT
UC Davis Health expert available to discuss pancreatic cancer: Why it is so lethal, and why there is hope
20-Jul-2020 2:05 PM EDT
The Surge in Throat Cancer, Especially in Men
Humanpapilloma virus (HPV) is now the leading cause of certain types of throat cancer. Dr. Michael Moore, director of head and neck surgery at UC Davis and an HPV-related cancer expert, answers some tough questions about the trend and what can be...
31-Jul-2018 6:05 PM EDT
Oh, My Aching Head! the Who, What, Why and How to Cope with Migraine
Migraine headaches can strike any time and be debilitating, making it impossible to work or enjoy even life’s simple pleasures. They affect approximately 12 percent of the population living in the U.S. and are three times more prevalent in women...
27-Jun-2018 1:05 PM EDT
UC Davis Researcher Urges Caution on Engineered Stem Cells
In a commentary published in the Jan. 4 issue of the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell...
3-Jan-2018 5:05 PM EST
All the Rage, but Do They Work? UC Davis #ADHD Expert Offers Thoughts on #Fidget Toys
10-May-2017 3:05 PM EDT
See All Experts
RSS Feeds by Section